glp 1 and lightheadedness A study of more than 42,000 adults found that people already taking multiple blood pressure medications had a higher risk of dizziness, fainting, other low-blood-pressure (hypotension) events after starting GLP-1 drugs GLP-1s tied to elevated risk

This broad transcriptomic influence spans pathways involved in collagen synthesis, metalloproteinase regulation, antioxidant response, and copper-dependent enzyme activation, making GHK-Cu one of the most comprehensively profiled peptides in in vitro research

The GLOW Protocol typically features a compounded peptide formulation containing: GHK-Cu 10 mg BPC-157 3 mg TB-500 3.75 mg per mL This protocol is typically used as part of a 30-day regimen , though treatment recommendations may vary depending on the patient, goals, and provider guidance

Administered as a daily subcutaneous injection with doses escalated over five weeks to a maintenance dose of 3.0mg

Every patients situation is unique

Promotes Wound Healing: Accelerates recovery and minimizes scarring Activates Immune Cells: Supports skin health and combats inflammation Provides Antioxidant and Anti-inflammatory Effects: Protects against environmental damage and premature aging Stimulates Collagen and Glycosaminoglycan Synthesis: Improves skin elasticity, reduces the appearance of wrinkles and fine lines